glycyl-arginyl-glycyl-aspartyl-serine has been researched along with leupeptin in 1 studies
| Studies (glycyl-arginyl-glycyl-aspartyl-serine) | Trials (glycyl-arginyl-glycyl-aspartyl-serine) | Recent Studies (post-2010) (glycyl-arginyl-glycyl-aspartyl-serine) | Studies (leupeptin) | Trials (leupeptin) | Recent Studies (post-2010) (leupeptin) |
|---|---|---|---|---|---|
| 190 | 0 | 42 | 944 | 0 | 74 |
| Protein | Taxonomy | glycyl-arginyl-glycyl-aspartyl-serine (IC50) | leupeptin (IC50) |
|---|---|---|---|
| Plasminogen | Homo sapiens (human) | 1.2 | |
| Cationic trypsin | Bos taurus (cattle) | 8.1 | |
| Trypsin | Sus scrofa (pig) | 0.5 | |
| Papain | Carica papaya (papaya) | 0.0022 | |
| Plasminogen | Bos taurus (cattle) | 3.7 | |
| Trypsin-1 | Homo sapiens (human) | 0.6 | |
| Trypsin-2 | Homo sapiens (human) | 0.6 | |
| Cathepsin B | Bos taurus (cattle) | 0.31 | |
| Procathepsin L | Homo sapiens (human) | 0.0045 | |
| Cathepsin B | Homo sapiens (human) | 0.0282 | |
| Trypsin-3 | Homo sapiens (human) | 0.6 | |
| Calpain-1 catalytic subunit | Sus scrofa (pig) | 0.08 | |
| Cysteine protease | Leishmania donovani | 0.01 | |
| Cysteine proteinase falcipain 2a | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0636 | |
| Cysteine protease falcipain-3 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.0925 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fridman, R; Hamilton, TC; Kanemoto, T; Martin, GR | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and leupeptin
| Article | Year |
|---|---|
Effects of synthetic peptides and protease inhibitors on the interaction of a human ovarian cancer cell line (NIH:OVCAR-3) with a reconstituted basement membrane (Matrigel).
Topics: Amides; Amino Acid Sequence; Aminocaproates; Antineoplastic Agents; Benzamidines; Biocompatible Materials; Cell Adhesion; Cell Line; Chemotaxis; Collagen; Dose-Response Relationship, Drug; Drug Combinations; Female; Glycoproteins; Humans; In Vitro Techniques; Laminin; Leupeptins; Metalloendopeptidases; Molecular Sequence Data; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Pepstatins; Polyamines; Protease Inhibitors; Proteoglycans; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Tyrosine | 1991 |